BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Celldex Therapeutics, Inc. 

222 Cameron Drive
Suite 400
Phillipsburg  New Jersey  08865  U.S.A.
Phone: 908-454-7120 Fax: 908-454-1911


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
TaiGen Biotechnology Announces Burixafor Collaboration With Celldex (CLDX) And The University Hospital Carl Gustav Carus Dresden In Germany 3/18/2015 6:39:31 AM
Celldex (CLDX) Announces Clinical Trial Collaboration With Roche (RHHBY) To Evaluate The Combination Of Varlilumab And MPDL3280A 3/17/2015 7:26:21 AM
Celldex (CLDX) Announces Upcoming Presentation At The Cowen and Company 35th Annual Health Care Conference 3/3/2015 8:36:27 AM
Celldex (CLDX) Announces Exercise Of Underwriters' Option To Purchase Additional Shares 3/2/2015 7:15:59 AM
Celldex (CLDX) Prices Public Offering Of Common Stock 2/26/2015 1:17:24 PM
Celldex (CLDX) Announces Proposed Public Offering Of Common Stock 2/25/2015 7:48:34 AM
Celldex (CLDX) Reports Fourth Quarter And Year-End 2014 Results 2/24/2015 10:34:29 AM
Celldex (CLDX)'s Rindopepimut (Rintega) Receives FDA Breakthrough Therapy Designation For The Treatment Of Adult Patients With Egfrviii-Positive Glioblastoma 2/23/2015 9:33:25 AM
Celldex (CLDX)'s Rindopepimut Deemed a Breakthrough By the FDA 2/23/2015 7:27:38 AM
Celldex Therapeutics, Inc. (CLDX) To Report Fourth Quarter And Fiscal 2014 Business/Financial Results And Host 2015 Corporate Strategy Conference Call 2/20/2015 7:32:56 AM
12345678910...